Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 4975 in Painful Intermetatarsal Neuroma
NCT00130962Phase 2Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Sep 2004
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin in intermetatarsal neuroma, sponsored by AlgoRx Pharmaceuticals. Started Sep 2004; status: completed.
02
Drugs
capsaicin
03
Conditions
intermetatarsal neuroma
Beyond the preview
Go deeper on NCT00130962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130962.